Wessling GmbH

Poland

All drugs from this manufacturer

  • AZACITIDINE ONKO

    The medicine is used in adults (who are not eligible for stem cell transplantation) for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

    Dosage form: powder for preparation of injection suspension

    Active substance Dosage
    azacitidine 25 mg/ml

    ATC: L01BC07